通貨 / KNSA
KNSA: Kiniksa Pharmaceuticals Ltd - Class A
28.09
USD
0.65
(2.26%)
KNSAの今日の為替レートは、-2.26%変化しました。日中、通貨は1あたり27.93の安値と28.74の高値で取引されました。
Kiniksa Pharmaceuticals Ltd - Class Aダイナミクスに従います。リアルタイムの相場は、市場の変化に迅速に対応するのに役立ちます。 異なる時間枠に切り替えることで、為替レートの傾向とダイナミクスを分、時間、日、週、月単位で監視できます。この情報を使用して、市場の変化を予測し、十分な情報に基づいて取引を決定してください。
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
KNSA News
- Investor's Business Daily Chip Gear Maker KLA In The Spotlight, Hits Record High: Looking For The Best Stocks To Buy And Watch? Check These Lists
- Investor's Business Daily Rubrik, Shopify, Nasdaq Among IBD's Version Of The Magnificent Seven
- Investor's Business Daily Technology And Construction Names Join Top Stock Lists: Check Out Additions To IBD 50, Big Cap 20 And More
- The Motley Fool Kiniksa Pharmaceuticals: A 7.9 Score and Room for Growth
- Investor's Business Daily GE Aerospace Joins Big Cap 20. Which Other Stocks Just Came Onto IBD's Top Stock Screens?
- Investor's Business Daily Heart Drug Stock Rockets 20% On Sales, Boosts Outlook; Regeneron Pharma's Global Partnership Is Strong Tailwind
- Investor's Business Daily Nasdaq, S&P 500 Hit All-Time Highs; These Stocks Made It Happen: Check Out New Names On IBD 50, Big Cap 20, More
- Investing Kiniksa pharma COO Tessari sells $489k in shares
- Seeking Alpha Tracking Baker Brothers Portfolio – Q1 2025 Update
- Seeking Alpha Kiniksa Pharmaceuticals: Arcalyst Performs, KPL-387 Advancing Fast (NASDAQ:KNSA)
- Investing Oracle, GameStop Lead Market Cap Stock Movers on Thursday
- Investor's Business Daily Cameco Jumped Nearly 11% Monday; Here's Why. See New Names On The IBD 50, IPO Leaders, Big Cap 20 List And More.
- Investor's Business Daily GE Aerospace, Nvidia Among 13 New Names: Build Your Growth Stock Watchlist With The IBD 50, Big Cap 20, Other Top Stock Lists
- Investing KNSA stock soars to 52-week high, hits $29.71 amid robust gains
- Investing Connexa Pharmaceuticals at Jefferies Conference: Strategic Growth and Innovation
- Investing Kiniksa sets Phase 2/3 trial for heart drug KPL-387
- Investing Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences
- Benzinga Pony AI, Hims & Hers And Frontdoor Are Among Top 11 Mid-Cap Gainers Last Week (Apr 28-May 2): Are The Others In Your Portfolio? - Hims & Hers Health (NYSE:HIMS), Frontdoor (NASDAQ:FTDR), Pony AI (NASDAQ:PONY)
- Benzinga Honeywell Posts Better-Than-Expected Q1 Earnings, Joins Crown Holdings, Noble, Crane And Other Big Stocks Moving Higher On Tuesday - CECO Environmental (NASDAQ:CECO), Crown Holdings (NYSE:CCK)
- Investing Citi says SMid biotechs alternative to large caps as it starts coverage
- Benzinga Kiniksa Pharmaceuticals Stock Is Attractive From Valuation Perspective-JP Morgan Analyst - Kiniksa Pharmaceuticals (NASDAQ:KNSA)
- Seeking Alpha Big Pipeline Updates From Kiniksa Pharmaceuticals (NASDAQ:KNSA)
- Seeking Alpha Kiniksa Pharmaceuticals: Strong Improvement In Arcalyst Revenue, But Risks Remain
1日のレンジ
27.93
28.74
1年のレンジ
17.82
30.68
- 以前の終値
- 28.95
- 始値
- 28.74
- 買値
- 28.09
- 買値
- 28.39
- 安値
- 27.93
- 高値
- 28.74
- 出来高
- 967
- 1日の変化
- -2.26%
- 1ヶ月の変化
- 1.96%
- 6ヶ月の変化
- 43.98%
- 1年の変化
- 5.40%
13 7月, 日曜日